• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰素γ基因低甲基化作为原发性高血压的潜在危险因素:一项病例对照研究。

Hypomethylation of the Interferon γ Gene as a Potential Risk Factor for Essential Hypertension: A Case-Control Study.

作者信息

Bao Xing-Jie, Mao Shu-Qi, Gu Tian-Lun, Zheng Shu-Ying, Zhao Jin-Shun, Zhang Li-Na

机构信息

Department of Preventive Medicine, Zhejiang Provincial Key Laboratory of Pathological and Physiological Technology, Medical School of Ningbo University.

Beilun District Center for Disease Control and Prevention.

出版信息

Tohoku J Exp Med. 2018 Apr;244(4):283-290. doi: 10.1620/tjem.244.283.

DOI:10.1620/tjem.244.283
PMID:29643275
Abstract

Essential hypertension (EH) is a multifactorial disease. Interferon-γ (IFN-γ) plays an important role in the onset of EH through cytokine-mediated systemic inflammatory responses. We aimed to determine whether the methylation status of the IFN-γ gene (IFNG) promoter is involved in the pathogenesis of EH. Six copies of CpG dinucleotides are distributed between 3,203 bp and 3,121 bp upstream from the transcription initiation site of IFNG, termed CpG1 to CpG6 in the 5'-to-3' direction. We recruited 96 patients with EH and 96 sex- and age-matched healthy subjects as controls. Using bisulfate pyrosequencing datasets, we analyzed the methylation status of the six CpG sites and thus found that CpG5 was consistently methylated in all of the 96 EH patients and 96 control subjects. Among the remaining five CpG sites, there was no significant difference in the methylation levels of CpG4 and CpG6 between the two groups. By contrast, CpG1 (P = 0.003) and CpG3 (P = 5.87 × 10) were highly methylated among the EH subjects compared with the controls, whereas CpG2 (P = 1.24 × 10) was significantly less methylated in among EH subjects. The methylation levels of CpG2 were still lower after adjustment with logistic regression (adjusted P = 0.032). The CpG2 methylation level was an effective marker of EH (area under curve = 0.384; P = 1.40 × 10). The present study shows that hypomethylation of the IFNG promoter is significantly related to the risk of EH, providing new insights into the pathogenesis of EH.

摘要

原发性高血压(EH)是一种多因素疾病。干扰素-γ(IFN-γ)通过细胞因子介导的全身炎症反应在EH的发病机制中起重要作用。我们旨在确定IFN-γ基因(IFNG)启动子的甲基化状态是否参与EH的发病机制。六个CpG二核苷酸拷贝分布在IFNG转录起始位点上游3203 bp至3121 bp之间,从5'到3'方向称为CpG1至CpG6。我们招募了96例EH患者和96例性别和年龄匹配的健康受试者作为对照。使用亚硫酸氢盐焦磷酸测序数据集,我们分析了六个CpG位点的甲基化状态,结果发现96例EH患者和96例对照受试者中CpG5均持续甲基化。在其余五个CpG位点中,两组之间CpG4和CpG6的甲基化水平无显著差异。相比之下,与对照组相比,EH受试者中CpG1(P = 0.003)和CpG3(P = 5.87×10)高度甲基化,而EH受试者中CpG2(P = 1.24×10)甲基化程度明显较低。经逻辑回归调整后,CpG2的甲基化水平仍然较低(调整后P = 0.032)。CpG2甲基化水平是EH的有效标志物(曲线下面积 = 0.384;P = 1.40×10)。本研究表明,IFNG启动子的低甲基化与EH风险显著相关,为EH的发病机制提供了新的见解。

相似文献

1
Hypomethylation of the Interferon γ Gene as a Potential Risk Factor for Essential Hypertension: A Case-Control Study.干扰素γ基因低甲基化作为原发性高血压的潜在危险因素:一项病例对照研究。
Tohoku J Exp Med. 2018 Apr;244(4):283-290. doi: 10.1620/tjem.244.283.
2
Hypomethylation of interleukin-6 (IL-6) gene increases the risk of essential hypertension: a matched case-control study.白细胞介素-6(IL-6)基因低甲基化增加原发性高血压风险:一项配对病例对照研究。
J Hum Hypertens. 2017 Aug;31(8):530-536. doi: 10.1038/jhh.2017.7. Epub 2017 Mar 16.
3
Hypomethylation of the Toll-like receptor-2 gene increases the risk of essential hypertension.Toll样受体2基因的低甲基化增加原发性高血压的风险。
Mol Med Rep. 2017 Jul;16(1):964-970. doi: 10.3892/mmr.2017.6653. Epub 2017 May 30.
4
Preliminary analysis of the association between methylation of the ACE2 promoter and essential hypertension.血管紧张素转换酶2启动子甲基化与原发性高血压之间关联的初步分析。
Mol Med Rep. 2017 Jun;15(6):3905-3911. doi: 10.3892/mmr.2017.6460. Epub 2017 Apr 11.
5
Association of AGTR1 Promoter Methylation Levels with Essential Hypertension Risk: A Matched Case-Control Study.AGTR1基因启动子甲基化水平与原发性高血压风险的关联:一项配对病例对照研究。
Cytogenet Genome Res. 2015;147(2-3):95-102. doi: 10.1159/000442366. Epub 2015 Dec 12.
6
Interactions between Promoter Methylation and Smoking Increase Risk of Essential Hypertension.启动子甲基化与吸烟之间的相互作用增加原发性高血压风险。
Biomed Res Int. 2016;2016:1454186. doi: 10.1155/2016/1454186. Epub 2016 Dec 19.
7
α-Adducin gene promoter DNA methylation and the risk of essential hypertension.α-辅肌动蛋白基因启动子 DNA 甲基化与原发性高血压的风险。
Clin Exp Hypertens. 2017;39(8):764-768. doi: 10.1080/10641963.2017.1324481. Epub 2017 Jul 7.
8
Association of SCNN1B promoter methylation with essential hypertension.SCNN1B启动子甲基化与原发性高血压的关联。
Mol Med Rep. 2016 Dec;14(6):5422-5428. doi: 10.3892/mmr.2016.5905. Epub 2016 Oct 31.
9
Aberrant methylation of the GCK gene body is associated with the risk of essential hypertension.GCK基因体的异常甲基化与原发性高血压风险相关。
Mol Med Rep. 2015 Aug;12(2):2390-4. doi: 10.3892/mmr.2015.3631. Epub 2015 Apr 16.
10
Lower ADD1 gene promoter DNA methylation increases the risk of essential hypertension.ADD1 基因启动子 DNA 低甲基化增加了原发性高血压的风险。
PLoS One. 2013 May 15;8(5):e63455. doi: 10.1371/journal.pone.0063455. Print 2013.

引用本文的文献

1
Natural Bioproducts with Epigenetic Properties for Treating Cardiovascular Disorders.具有表观遗传特性的天然生物制品用于治疗心血管疾病。
Genes (Basel). 2025 May 10;16(5):566. doi: 10.3390/genes16050566.
2
Therapeutic Potential of Natural Compounds Acting through Epigenetic Mechanisms in Cardiovascular Diseases: Current Findings and Future Directions.天然化合物通过表观遗传机制在心血管疾病中的治疗潜力:当前的发现和未来的方向。
Nutrients. 2024 Jul 24;16(15):2399. doi: 10.3390/nu16152399.
3
Epigenetics of hypertension as a risk factor for the development of coronary artery disease in type 2 diabetes mellitus.
高血压的表观遗传学作为 2 型糖尿病患者发生冠心病的危险因素。
Front Endocrinol (Lausanne). 2024 May 21;15:1365738. doi: 10.3389/fendo.2024.1365738. eCollection 2024.
4
DNA Methylation of the IL-17A Gene Promoter Is Associated with Subclinical Atherosclerosis and Coronary Artery Disease: The Genetics of Atherosclerotic Disease Mexican Study.白细胞介素-17A基因启动子的DNA甲基化与亚临床动脉粥样硬化和冠状动脉疾病相关:动脉粥样硬化疾病遗传学墨西哥研究
Curr Issues Mol Biol. 2023 Dec 5;45(12):9768-9777. doi: 10.3390/cimb45120610.
5
Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials.心血管疾病中的表观遗传调控:机制与临床试验进展。
Signal Transduct Target Ther. 2022 Jun 25;7(1):200. doi: 10.1038/s41392-022-01055-2.
6
Roles and Mechanisms of DNA Methylation in Vascular Aging and Related Diseases.DNA甲基化在血管衰老及相关疾病中的作用与机制
Front Cell Dev Biol. 2021 Jun 28;9:699374. doi: 10.3389/fcell.2021.699374. eCollection 2021.
7
Left heart function evaluation of patients with essential hypertension and paroxysmal atrial fibrillation by two-dimensional speckle tracking imaging combined with real-time three-dimensional ultrasound imaging.二维斑点追踪成像联合实时三维超声心动图对原发性高血压合并阵发性心房颤动患者左心功能的评估
J Thorac Dis. 2021 Jan;13(1):322-333. doi: 10.21037/jtd-20-3577.
8
The role of DNA methylation and histone modifications in blood pressure: a systematic review.DNA 甲基化和组蛋白修饰在血压中的作用:系统综述。
J Hum Hypertens. 2019 Oct;33(10):703-715. doi: 10.1038/s41371-019-0218-7. Epub 2019 Jul 25.
9
Epigenetic modification: a regulatory mechanism in essential hypertension.表观遗传修饰:原发性高血压的一种调控机制。
Hypertens Res. 2019 Aug;42(8):1099-1113. doi: 10.1038/s41440-019-0248-0. Epub 2019 Mar 13.